Health and Healthcare

MannKind : MNKD

All MannKind Articles

305 Articles

Jon C. Ogg | Jan 22, 2011 at 10:52 AM EST

The Top 5 Analyst Calls of the Week, Or Top 6 Calls (FFIV, MNKD, PDLI, SBIB, CMA, GOOG, AAPL)

We always look for standout research calls. The goal is not to just find bullish calls, but calls which have…

Douglas A. McIntyre | Jan 20, 2011 at 8:28 AM EST

Top Active Trader Alert Stocks (CYTX, EBAY, FFIV, FITB, MNKD)

Active traders and day traders have many stocks to choose from this Thursday morning. We are tracking news and moves…

Jon C. Ogg | Jan 20, 2011 at 8:05 AM EST

Top Analyst Upgrades & Downgrades (ALTR, BHI, CIM, FFIV, FLR, GS, HCBK, MNKD, MEE, MU, SHAW, TYC)

These are some of this Thursday’s top analyst calls with upgrades, downgrades, and initiations seen from Wall Street research firms.…

Jon C. Ogg | Dec 20, 2010 at 8:18 AM EST

Top Analyst Upgrades and Downgrades (ARG, AGNC, BRCM, CIM, CME, FSLR, HBAN, ICE, MNKD, MCD, MFA, MGI, NFLX, NTAP, ORCL, SNCR, VRTX)

These are some of this Monday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Airgas Inc.…

Jon C. Ogg | Nov 6, 2010 at 12:07 PM EDT

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

Biotech and emerging pharma both seem to have almost no friends today despite a large stock market rally. It may…

Jon C. Ogg | Aug 19, 2010 at 9:03 AM EDT

Top Day Trader Alerts (SYMC, CHKP, BRCD, BSDM, MNKD, NTAP, PETM, STEM)

Day traders and active traders have many movers this Wednesday morning to choose from. The top alerts were seen in…

Jon C. Ogg | Aug 17, 2010 at 8:58 AM EDT

Top Day Trader Alerts (POT, CAGC, SEED, FISV, MNKD, PEIX, PTV, RIMM, RICK, TOO)

Many stocks are on the move this Tuesday. Our top day trader alerts and active trader alerts are seen in…

Jon C. Ogg | May 24, 2010 at 1:20 PM EDT

BioHealth Business Daily (CTIC, DNDN, HGSI, MNKD, NVAX, RGEN, SQNM, VVUS)

Today is a strange day in biotech. We have big moves in many key names, but this is not the…

Jon C. Ogg | Mar 22, 2010 at 12:57 PM EDT

BioHealth Business Daily (CTIC, DNDN, MNKD, VPHM, SOMX, SQNM, TEVA, RNN, BIIB)

Monday is seeing many winners and losers in the healthcare sector on the heels of the health care reform passage…

Douglas A. McIntyre | Jan 9, 2010 at 10:23 AM EST

The Unusual Suspects (AA, INTC, JPM, BRK-A, CYCC, GENZ, IMMU, MNKD, QCOM, SWC)

There are many companies that deserved to be on this weekend’s slate of unusual suspects that have key current developments to…

Douglas A. McIntyre | Sep 9, 2009 at 9:27 AM EDT

Top Day Trader Alerts (GE, PALM, VVUS, OREX, ARNA, MNKD)

Here are Wednesday’s top day trader and active trader alerts with more detailed trading volume and price analysis in the…

Douglas A. McIntyre | Aug 10, 2009 at 10:56 AM EDT

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so…

Douglas A. McIntyre | Aug 5, 2009 at 1:28 PM EDT

Long Line of Biotech Secondary Stock Offerings (MNKD, IDIX, ISPH, ARIA, ONTY, NBY, SOMX, ARNA, OXGN)

It seems that there is another endless line of biotech and emerging pharmaceutical companies which have raised cash or have…

Douglas A. McIntyre | Aug 5, 2009 at 9:55 AM EDT

MannKind Raises Over $50 Million (MNKD, PFE)

MannKind Corporation (NASDAQ: MNKD) is getting hit after the company announced that it priced a secondary offering of 7,400,000 shares…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

1 … 18 19 20 21

MannKind : MNKD

All MannKind Articles

The Top 5 Analyst Calls of the Week, Or Top 6 Calls (FFIV, MNKD, PDLI, SBIB, CMA, GOOG, AAPL)

Top Active Trader Alert Stocks (CYTX, EBAY, FFIV, FITB, MNKD)

Top Analyst Upgrades & Downgrades (ALTR, BHI, CIM, FFIV, FLR, GS, HCBK, MNKD, MEE, MU, SHAW, TYC)

Top Analyst Upgrades and Downgrades (ARG, AGNC, BRCM, CIM, CME, FSLR, HBAN, ICE, MNKD, MCD, MFA, MGI, NFLX, NTAP, ORCL, SNCR, VRTX)

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

Top Day Trader Alerts (SYMC, CHKP, BRCD, BSDM, MNKD, NTAP, PETM, STEM)

Top Day Trader Alerts (POT, CAGC, SEED, FISV, MNKD, PEIX, PTV, RIMM, RICK, TOO)

BioHealth Business Daily (CTIC, DNDN, HGSI, MNKD, NVAX, RGEN, SQNM, VVUS)

BioHealth Business Daily (CTIC, DNDN, MNKD, VPHM, SOMX, SQNM, TEVA, RNN, BIIB)

The Unusual Suspects (AA, INTC, JPM, BRK-A, CYCC, GENZ, IMMU, MNKD, QCOM, SWC)

Top Day Trader Alerts (GE, PALM, VVUS, OREX, ARNA, MNKD)

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Long Line of Biotech Secondary Stock Offerings (MNKD, IDIX, ISPH, ARIA, ONTY, NBY, SOMX, ARNA, OXGN)

MannKind Raises Over $50 Million (MNKD, PFE)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Fed’s Rate Freeze Could Sting for Social Security Recipients

MannKind : MNKD

All MannKind Articles

The Top 5 Analyst Calls of the Week, Or Top 6 Calls (FFIV, MNKD, PDLI, SBIB, CMA, GOOG, AAPL)

Top Active Trader Alert Stocks (CYTX, EBAY, FFIV, FITB, MNKD)

Top Analyst Upgrades & Downgrades (ALTR, BHI, CIM, FFIV, FLR, GS, HCBK, MNKD, MEE, MU, SHAW, TYC)

Top Analyst Upgrades and Downgrades (ARG, AGNC, BRCM, CIM, CME, FSLR, HBAN, ICE, MNKD, MCD, MFA, MGI, NFLX, NTAP, ORCL, SNCR, VRTX)

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

Top Day Trader Alerts (SYMC, CHKP, BRCD, BSDM, MNKD, NTAP, PETM, STEM)

Top Day Trader Alerts (POT, CAGC, SEED, FISV, MNKD, PEIX, PTV, RIMM, RICK, TOO)

BioHealth Business Daily (CTIC, DNDN, HGSI, MNKD, NVAX, RGEN, SQNM, VVUS)

BioHealth Business Daily (CTIC, DNDN, MNKD, VPHM, SOMX, SQNM, TEVA, RNN, BIIB)

The Unusual Suspects (AA, INTC, JPM, BRK-A, CYCC, GENZ, IMMU, MNKD, QCOM, SWC)

Top Day Trader Alerts (GE, PALM, VVUS, OREX, ARNA, MNKD)

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Long Line of Biotech Secondary Stock Offerings (MNKD, IDIX, ISPH, ARIA, ONTY, NBY, SOMX, ARNA, OXGN)

MannKind Raises Over $50 Million (MNKD, PFE)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s